Oscar Health Announces Results for Fourth Quarter and Full Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Oscar Health Inc (OSCR) PT Lowered to $8 at Cowen
February 11, 2022 7:10 AM ESTCowen analyst Gary Taylor lowered the price target on Oscar Health Inc (NYSE: OSCR) to $8.00 (from $15.00) while maintaining a Market Perform rating.
The analyst commented, "On 1/27/22 OSCR previewed 4Q21 results and initiated 2022 guidance. Full results tonight reveal a $40m PDR benefit in 4Q21;... More
Oscar Health Inc. (OSCR) Tops Q4 EPS by 12c
February 10, 2022 4:28 PM ESTOscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.95), $0.12 better than the analyst estimate of ($1.07). Revenue for the quarter came in at $496.07 million, versus $157.67 million reported last year.
Direct and assumed premiums of $3,437 million, a 50% increase YoYPremiums earned of $1,831 million, a 302%... More